153 related articles for article (PubMed ID: 21490239)
1. Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes.
Rudolph A; Sainz J; Hein R; Hoffmeister M; Frank B; Försti A; Brenner H; Hemminki K; Chang-Claude J
Endocr Relat Cancer; 2011 Jun; 18(3):371-84. PubMed ID: 21490239
[TBL] [Abstract][Full Text] [Related]
2. Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.
Sainz J; Rudolph A; Hein R; Hoffmeister M; Buch S; von Schönfels W; Hampe J; Schafmayer C; Völzke H; Frank B; Brenner H; Försti A; Hemminki K; Chang-Claude J
Endocr Relat Cancer; 2011 Apr; 18(2):265-76. PubMed ID: 21317201
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy.
Hein R; Abbas S; Seibold P; Salazar R; Flesch-Janys D; Chang-Claude J
Breast Cancer Res Treat; 2012 Jan; 131(2):653-61. PubMed ID: 21947678
[TBL] [Abstract][Full Text] [Related]
6. Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect.
Pechlivanis S; Pardini B; Bermejo JL; Wagner K; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
Endocr Relat Cancer; 2007 Sep; 14(3):733-40. PubMed ID: 17914103
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
[TBL] [Abstract][Full Text] [Related]
9. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene.
Kataoka N; Cai Q; Xu WH; Xiang YB; Cai H; Zheng W; Shu XO
Cancer; 2007 Apr; 109(7):1296-302. PubMed ID: 17315164
[TBL] [Abstract][Full Text] [Related]
10. Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population.
Canbay E; Cakmakoglu B; Zeybek U; Sozen S; Cacina C; Gulluoglu M; Balik E; Bulut T; Yamaner S; Bugra D
Curr Med Res Opin; 2011 Jul; 27(7):1295-302. PubMed ID: 21561390
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk.
Bethke L; Webb E; Sellick G; Rudd M; Penegar S; Withey L; Qureshi M; Houlston R
BMC Cancer; 2007 Jul; 7():123. PubMed ID: 17615053
[TBL] [Abstract][Full Text] [Related]
12. Death receptor 4 variants and colorectal cancer risk.
Frank B; Shanmugam KS; Beckmann L; Hemminki K; Brenner H; Hoffmeister M; Chang-Claude J; Burwinkel B
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):2002-5. PubMed ID: 17035413
[TBL] [Abstract][Full Text] [Related]
13. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy.
Hoffmeister M; Raum E; Krtschil A; Chang-Claude J; Brenner H
Clin Pharmacol Ther; 2009 Oct; 86(4):416-24. PubMed ID: 19606090
[TBL] [Abstract][Full Text] [Related]
14. Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer?
Tulupova E; Kumar R; Hanova M; Slyskova J; Pardini B; Polakova V; Naccarati A; Vodickova L; Novotny J; Halamkova J; Hemminki K; Vodicka P
Mutat Res; 2008 Dec; 648(1-2):40-5. PubMed ID: 18851982
[TBL] [Abstract][Full Text] [Related]
15. Association of hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD) variants and colorectal cancer risk.
Frank B; Hoeft B; Hoffmeister M; Linseisen J; Breitling LP; Chang-Claude J; Brenner H; Nieters A
Carcinogenesis; 2011 Feb; 32(2):190-6. PubMed ID: 21047993
[TBL] [Abstract][Full Text] [Related]
16. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.
Cui Y; Shu XO; Cai Q; Jin F; Cheng JR; Cai H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1096-101. PubMed ID: 15894658
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Int J Cancer; 2010 Jun; 126(12):2935-46. PubMed ID: 19739075
[TBL] [Abstract][Full Text] [Related]
19. The association of XPC polymorphisms and tea drinking with colorectal cancer risk in a Chinese population.
Wu Y; Jin M; Liu B; Liang X; Yu Y; Li Q; Ma X; Yao K; Chen K
Mol Carcinog; 2011 Mar; 50(3):189-98. PubMed ID: 21104992
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and risk of colon and rectal cancer.
Fernandez E; La Vecchia C; Braga C; Talamini R; Negri E; Parazzini F; Franceschi S
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):329-33. PubMed ID: 9568789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
